Parmax Pharma (BOM:540359) EV-to-Revenue : 0.82 (As of May. 29, 2025)

Parmax Pharma EV-to-Revenue Chart

Parmax Pharma Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
EV-to-Revenue		Get a 7-Day Free Trial					0.45	0.63	1.08	1.07	1.49

Parmax Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial															0.92	1.49	0.65	1.02	0.60

Competitive Comparison of Parmax Pharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Parmax Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parmax Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parmax Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Parmax Pharma's EV-to-Revenue falls into.

Parmax Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Parmax Pharma's EV-to-Revenue for today is calculated as:

Parmax Pharma's current Enterprise Value is ₹226.9 Mil.
Parmax Pharma's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹276.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parmax Pharma  (BOM:540359) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Parmax Pharma's PS Ratiofor today is calculated as:

Parmax Pharma's share price for today is ₹45.50.
Parmax Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹71.94.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parmax Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Parmax Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Parmax Pharma Business Description